Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 10,344 | 11,200 | 9,161 | 18,817 | 20,574 |
| Cost of Goods | 5,609 | 9,659 | 8,087 | 15,224 | 19,005 |
| Gross Profit | 4,735 | 1,542 | 1,075 | 3,593 | 1,569 |
| Operating Expenses | 8,722 | 8,191 | 7,379 | 11,867 | 14,804 |
| Operating Income | -3,379 | -5,991 | -6,218 | -8,050 | -13,230 |
| Interest Expense | 643 | 708 | 728 | 734 | 737 |
| Other Income | 3,195 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -827 | -6,699 | -6,946 | -8,784 | -13,967 |
| Income Tax | 28 | 0 | 0 | 6 | 6 |
| Net Income Continuous | -856 | -6,699 | -6,946 | -8,790 | -13,973 |
| Net Income | $-855 | $-6,699 | $-6,946 | $-8,790 | $-13,973 |
| EPS Basic Total Ops | 0.01 | -0.21 | -0.23 | -0.29 | -0.49 |
| EPS Basic Continuous Ops | 0.01 | -0.21 | -0.23 | -0.29 | -0.49 |
| EPS Diluted Total Ops | 0.01 | -0.21 | -0.23 | -0.29 | -0.49 |
| EPS Diluted Continuous Ops | 0.01 | -0.21 | -0.23 | -0.29 | -0.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.21 | -0.23 | -0.29 | -0.32 |
| EBITDA(a) | $-2,693 | $-5,336 | $-5,605 | $-7,452 | $-12,486 |